Trial: 202006130

CRESTONE: A Phase 2 Study of Seribantumab in Adult Patients with Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors

Phase

II (Cancer Control)

Principal Investigator

Waqar, Saiama

Disease Site

Colon; Lung; Other Digestive Organ; Pancreas; Rectum

Learn more about this study at: clinicaltrials.gov